Journal of Stroke

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke

Jay Chol Choi, Ji Sung Lee, Tai Hwan Park, Sang-Soon Park, Yong-Jin Cho, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Soo-Joo Lee, Youngchai Ko, Jae Guk Kim, Jun Lee, Ki-Hyun Cho, Joon-Tae Kim, Kyung-Ho Yu, Byung-Chul Lee, Mi-Sun Oh, Jae-Kwan Cha, Dae-Hyun Kim, Hyun-Wook Nah, Dong-Eog Kim, Wi-Sun Ryu, Beom Joon Kim, Hee-Joon Bae, Wook-Joo Kim, Dong-Ick Shin, Min-Ju Yeo, Sung Il Sohn, Jeong-Ho Hong, Juneyoung Lee, Keun-Sik Hong

J Stroke. 2015;17(3):327-335. Published online September 30, 2015
DOI: https://doi.org/10.5853/jos.2015.17.3.327

Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke

Marc Quinlan

The Journal of Emergency Medicine. 2013;45(5):810

Link1 Link2

Consensus Statement on the Use of Intravenous Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke by the Chinese Stroke Therapy Expert Panel

An-Ding Xu, Yong-Jun Wang, David Z Wang,

CNS Neuroscience & Therapeutics. 2013;19(8):543-548

Link1

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients

A.A. Rabinstein

Yearbook of Neurology and Neurosurgery. 2007;2007:15-17

Link1 Link2

Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke

A.A. Rabinstein

Yearbook of Neurology and Neurosurgery. 2011;2011:10-11

Link1 Link2

Risk of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with Intravenous Tissue Plasminogen Activator

Howard Kim

The Journal of Emergency Medicine. 2012;43(5):e379

Link1 Link2

0058 Circadian Variation Of The Efficacy Of Intravenous Recombinant Tissue Plasminogen Activator In Patients With Acute Ischemic Stroke

J Kim, S Lee

Sleep. 2018;41(suppl_1):A23-A24

Link1

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years

Gioia Mione, Xavier Ducrocq, Nathalie Thilly, Jean-Christophe Lacour, Hervé Vespignani, Sébastien Richard

Geriatrics & Gerontology International. 2015;16(7):843-849

Link1

The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke

Julie E. Buijs, Maarten Uyttenboogaart, Raf Brouns, Jacques de Keyser, Pieter Willem Kamphuisen, Gert-Jan Luijckx

Journal of Stroke and Cerebrovascular Diseases. 2016;25(2):312-316

Link1 Link2

Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry

Ryu Matsuo, Masahiro Kamouchi, Tetsuro Ago, Jun Hata, Yuji Shono, Junya Kuroda, Yoshinobu Wakisaka, Hiroshi Sugimori, Takanari Kitazono,

Geriatrics & Gerontology International. 2013;14(4):954-959

Link1

Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke

Jennifer E. Fugate, Alejandro A. Rabinstein

Mayo Clinic Proceedings. 2014;89(7):960-972

Link1 Link2